(Q34229017)

31 July 2017

title

Lactonase and lactonizing activities of human serum paraoxonase (PON1) and rabbit serum PON3. (English)

1 reference

31 July 2017

John F Teiber

1

1 reference

31 July 2017

Dragomir I Draganov

series ordinal

2

1 reference

31 July 2017

Bert N La Du

series ordinal

3

1 reference

31 July 2017

language of work or name

English

0 references

publication date

1 September 2003

1 reference

31 July 2017

published in

Biochemical Pharmacology

1 reference

31 July 2017

volume

66

1 reference

31 July 2017

issue

6

1 reference

31 July 2017

page(s)

887-896

1 reference

Multiple substrates for paraoxonase-1 during oxidation of phosphatidylcholine by peroxynitrite

31 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Protective effect of high density lipoprotein associated paraoxonase. Inhibition of the biological activity of minimally oxidized low density lipoprotein

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Paraoxonase active site required for protection against LDL oxidation involves its free sulfhydryl group and is different from that required for its arylesterase/paraoxonase activities: selective action of human paraoxonase allozymes Q and R

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Paraoxonase and atherosclerosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

The molecular basis of the human serum paraoxonase activity polymorphism.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

The effect of the human serum paraoxonase polymorphism is reversed with diazoxon, soman and sarin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

The human serum paraoxonase/arylesterase gene (PON1) is one member of a multigene family

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Selective plasma hydrolysis of glucocorticoid gamma-lactones and cyclic carbonates by the enzyme paraoxonase: an ideal plasma inactivation mechanism

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Rabbit serum paraoxonase 3 (PON3) is a high density lipoprotein-associated lactonase and protects low density lipoprotein against oxidation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

A kinetic and mechanistic study of the hydrolysis of camptothecin and some analogues

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

The interconversion kinetics, equilibrium, and solubilities of the lactone and hydroxyacid forms of the HMG-CoA reductase inhibitor, CI-981

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Kinetics and Mechanisms of Lactonization of Coumarinic Acids and Hydrolysis of Coumarins I

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

The FEMA GRAS assessment of lactones used as a flavour ingredients. The Flavor and Extract Manufacturers' Association. Generally recognized as safe

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Resolvins: a family of bioactive products of omega-3 fatty acid transformation circuits initiated by aspirin treatment that counter proinflammation signals

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Glucuronidation of statins in animals and humans: a novel mechanism of statin lactonization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Glucuronidation of the dietary fatty acids, phytanic acid and docosahexaenoic acid, by human UDP-glucuronosyltransferases

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

The mammalian carboxylesterases: from molecules to functions.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Human paraoxonase-3 is an HDL-associated enzyme with biological activity similar to paraoxonase-1 protein but is not regulated by oxidized lipids

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Bioactions of 5-hydroxyicosatetraenoate and its interaction with platelet-activating factor

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Epoxyeicosatrienoic acids and dihydroxyeicosatrienoic acids are potent vasodilators in the canine coronary microcirculation.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

Iodolactones and iodoaldehydes--mediators of iodine in thyroid autoregulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0006-2952%2803%2900401-5

10.1016/S0006-2952(03)00401-5

7 January 2021

Identifiers

DOI

1 reference

31 July 2017

1 reference